PNPLA3 and metabolic dysfunction-associated steatotic liver disease: It is intriguing to investigate whether metabolic comorbidities such as obesity and insulin resistance, which are associated with the pathogenesis of NAFLD, are also influenced by the PNPLA3 I148M variant.